SEC
Filing

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 27, 2020
Document Date
Mar 27, 2020
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe